Letter: Hepatocellular Carcinoma Risk After Hepatitis B Surface Antigen Seroclearance - Authors’ Reply
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14026
Full Text
Open PDFAbstract
Available in full text
Date
April 3, 2017
Authors
Publisher
Wiley